Yong-Jun Huh
Directeur Général chez GREEN CROSS HOLDINGS CORPORATION
Fortune : 17 M $ au 31/05/2024
Profil
Yong-Jun Huh is currently the Co-Chief Executive Officer, Director & VP at Green Cross Holdings Corp.
and a Director at Artiva Biotherapeutics, Inc. He previously worked as a Director at GREEN CROSS WellBeing Corp.
and as an Executive Vice President at Green Cross Corp.
Huh holds an MBA from the University of Wisconsin and an undergraduate degree from Yonsei University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2024 | 1 367 454 ( 2,91% ) | 14 M $ | 31/05/2024 | |
| 31/12/2022 | 300 000 ( 1,69% ) | 2 M $ | 31/05/2024 | |
GC CELL CORPORATION
0,20% | 30/09/2023 | 31 000 ( 0,20% ) | 759 019 $ | 31/05/2024 |
Postes actifs de Yong-Jun Huh
| Sociétés | Poste | Début |
|---|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Directeur Général | 01/03/2010 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/09/2019 |
Anciens postes connus de Yong-Jun Huh
| Sociétés | Poste | Fin |
|---|---|---|
| GC BIOPHARMA CORP. | Corporate Officer/Principal | - |
| GREEN CROSS WELLBEING CORPORATION | Directeur/Membre du Conseil | - |
Formation de Yong-Jun Huh
| Yonsei University | Undergraduate Degree |
| University of Wisconsin | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Health Technology |
| GC BIOPHARMA CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| GREEN CROSS WellBeing Corp. | |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
